161 related articles for article (PubMed ID: 34957924)
1. Inferior survival and frequent hepatic dysfunction in non-Hodgkin's lymphoma patients with HBV infection: a systematic review and meta-analysis.
Zhang MY; Gao F; Zhao YW; Ni BW; Huang HH; Hou J
Hematology; 2022 Dec; 27(1):70-79. PubMed ID: 34957924
[TBL] [Abstract][Full Text] [Related]
2. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin's lymphoma: a systematic review and meta-analysis.
Zhang M; Gao F; Peng L; Shen L; Zhao P; Ni B; Hou J; Huang H
Cancer Cell Int; 2021 Oct; 21(1):524. PubMed ID: 34627251
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.
Wang F; Xu RH; Luo HY; Zhang DS; Jiang WQ; Huang HQ; Sun XF; Xia ZJ; Guan ZZ
BMC Cancer; 2008 Apr; 8():115. PubMed ID: 18433487
[TBL] [Abstract][Full Text] [Related]
4. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.
Chen J; Wang J; Yang J; Zhang W; Song X; Chen L
PLoS One; 2013; 8(7):e69400. PubMed ID: 23861969
[TBL] [Abstract][Full Text] [Related]
5. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
[TBL] [Abstract][Full Text] [Related]
6. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin's lymphoma.
Kadry DY; Elbahnasawy MA; Mansour MT; El Gebaly OK; Aziz H; Kamel MM; Abdel-Moneim AS; Radwan S
Int J Immunopathol Pharmacol; 2023; 37():3946320231207342. PubMed ID: 37859403
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
[TBL] [Abstract][Full Text] [Related]
8. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
Lim ST; Fei G; Quek R; Lim LC; Lee LH; Yap SP; Loong S; Tao M
Eur J Haematol; 2007 Aug; 79(2):132-7. PubMed ID: 17635237
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.
Cheng CL; Huang SC; Chen JH; Wei CH; Fang WQ; Su TH; Yuan CT; Liu JH; Chuang MK; Tien HF
Oncologist; 2020 Sep; 25(9):793-802. PubMed ID: 32275807
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels EA; Cho ER; Jee SH
Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis.
Nath A; Agarwal R; Malhotra P; Varma S
Intern Med J; 2010 Sep; 40(9):633-41. PubMed ID: 19811561
[TBL] [Abstract][Full Text] [Related]
14. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphomas and carrier state of viral hepatitis B and C.
Grudeva-Popova J; Nenova I; Mateva N; Ananoshtev N; Popov V; Atanasova M
J BUON; 2013; 18(1):239-44. PubMed ID: 23613411
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinical characteristics and prognostic factors in patients with non-Hodgkin lymphoma and HBV infection].
Zhang L; Yuan XL; Jiang L; Yang J; Guo JM; Shi J; Lei PC; Zhang Y; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):563-568. PubMed ID: 30122015
[No Abstract] [Full Text] [Related]
19. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies.
Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H
J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era: Unique clinical features and worse outcomes.
Yan X; Zhou M; Lou Z; Mu Q; Sheng L; Zhang P; Wang Y; Ouyang G
J Cancer Res Ther; 2018; 14(Supplement):S248-S253. PubMed ID: 29578182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]